TITLE:
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
Lurasidone 80mg tablet

SUMMARY:

      A 1-year outpatient study to test the safety and tolerability of a new medication in the
      treatment of schizophrenia
    

DETAILED DESCRIPTION:

      Study will evaluate long-term safety and tolerability of a new compound in the treatment of
      patients with schizophrenia as assessed by adverse events (AEs), measures of extra pyramidal
      symptoms (EPS; Abnormal Involuntary Movement Scale [AIMS], Barnes Akathisia Scale [BAS], and
      Simpson-Angus Rating Scale [SAS]), vital sign measurements, electrocardiograms (ECGs),
      clinical laboratory evaluations.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 64 Years
Criteria:

        -  Patients must have participated in study D1050196 (A Study to Test the Effectiveness
             and Safety of a New Medication in the Treatment of Schizophrenia) and either:

          -  Successfully completed

          -  OR

          -  Patients must have been discontinued after a minimum of 2 weeks of treatment due to
             lack of efficacy
      
